154 related articles for article (PubMed ID: 30644437)
1. MORC2 regulates C/EBPα-mediated cell differentiation via sumoylation.
Liu J; Zhang Q; Ruan B; Chen W; Zheng J; Xu B; Jiang P; Miao Z; Li F; Guo JY; Cao L; Wang G
Cell Death Differ; 2019 Oct; 26(10):1905-1917. PubMed ID: 30644437
[TBL] [Abstract][Full Text] [Related]
2. Sumoylation of CCAAT/enhancer-binding protein alpha and its functional roles in hepatocyte differentiation.
Sato Y; Miyake K; Kaneoka H; Iijima S
J Biol Chem; 2006 Aug; 281(31):21629-21639. PubMed ID: 16735515
[TBL] [Abstract][Full Text] [Related]
3. Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer.
Zhang FL; Yang SY; Liao L; Zhang TM; Zhang YL; Hu SY; Deng L; Huang MY; Andriani L; Ma XY; Shao ZM; Li DQ
Theranostics; 2023; 13(3):973-990. PubMed ID: 36793866
[No Abstract] [Full Text] [Related]
4. PAK1-mediated MORC2 phosphorylation promotes gastric tumorigenesis.
Wang G; Song Y; Liu T; Wang C; Zhang Q; Liu F; Cai X; Miao Z; Xu H; Xu H; Cao L; Li F
Oncotarget; 2015; 6(12):9877-86. PubMed ID: 25888627
[TBL] [Abstract][Full Text] [Related]
5. By recruiting HDAC1, MORC2 suppresses p21 Waf1/Cip1 in gastric cancer.
Zhang Q; Song Y; Chen W; Wang X; Miao Z; Cao L; Li F; Wang G
Oncotarget; 2015 Jun; 6(18):16461-70. PubMed ID: 26098774
[TBL] [Abstract][Full Text] [Related]
6. Sumoylation of CCAAT-enhancer-binding protein α inhibits lung differentiation in Bronchopulmonary Dysplasia model rats.
Zhu Y; Chen X; Mi L; Wang Q; Zhu H; Ju H; Lu H
J Cell Mol Med; 2020 Jun; 24(12):7067-7071. PubMed ID: 32363643
[TBL] [Abstract][Full Text] [Related]
7. Chromatin remodeling protein MORC2 promotes breast cancer invasion and metastasis through a PRD domain-mediated interaction with CTNND1.
Liao XH; Zhang Y; Dong WJ; Shao ZM; Li DQ
Oncotarget; 2017 Nov; 8(58):97941-97954. PubMed ID: 29228664
[TBL] [Abstract][Full Text] [Related]
8. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p.
Liao G; Liu X; Wu D; Duan F; Xie X; Wen S; Li Y; Li S
Aging (Albany NY); 2019 Jun; 11(11):3639-3649. PubMed ID: 31180332
[TBL] [Abstract][Full Text] [Related]
9. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
[TBL] [Abstract][Full Text] [Related]
10. Genetic ablation of CCAAT/enhancer binding protein alpha in epidermis reveals its role in suppression of epithelial tumorigenesis.
Loomis KD; Zhu S; Yoon K; Johnson PF; Smart RC
Cancer Res; 2007 Jul; 67(14):6768-76. PubMed ID: 17638888
[TBL] [Abstract][Full Text] [Related]
11. HDAC3 interacts with sumoylated C/EBPα to negatively regulate the LXRα expression in rat hepatocytes.
Ren J; Li D; Li Y; Lan X; Zheng J; Wang X; Ma J; Lu S
Mol Cell Endocrinol; 2013 Jul; 374(1-2):35-45. PubMed ID: 23639777
[TBL] [Abstract][Full Text] [Related]
12. Destabilization of microrchidia family CW-type zinc finger 2 via the cyclin-dependent kinase 1-chaperone-mediated autophagy pathway promotes mitotic arrest and enhances cancer cellular sensitivity to microtubule-targeting agents.
Hu SY; Qian JX; Yang SY; Andriani L; Liao L; Deng L; Huang MY; Zhang YL; Zhang FL; Shao ZM; Li DQ
Clin Transl Med; 2023 Mar; 13(3):e1210. PubMed ID: 36967563
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia regulates the expression and localization of CCAAT/enhancer binding protein α by hypoxia inducible factor-1α in bladder transitional carcinoma cells.
Xue M; Li X; Chen W
Mol Med Rep; 2015 Aug; 12(2):2121-7. PubMed ID: 25824695
[TBL] [Abstract][Full Text] [Related]
14. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
Zhang L; Li DQ
Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
[TBL] [Abstract][Full Text] [Related]
15. Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.
Milde-Langosch K; Löning T; Bamberger AM
Breast Cancer Res Treat; 2003 May; 79(2):175-85. PubMed ID: 12825852
[TBL] [Abstract][Full Text] [Related]
16. C/EBPα in normal and malignant myelopoiesis.
Friedman AD
Int J Hematol; 2015 Apr; 101(4):330-41. PubMed ID: 25753223
[TBL] [Abstract][Full Text] [Related]
17. MORC2 Enhances Tumor Growth by Promoting Angiogenesis and Tumor-Associated Macrophage Recruitment via Wnt/β-Catenin in Lung Cancer.
Liu M; Sun X; Shi S
Cell Physiol Biochem; 2018; 51(4):1679-1694. PubMed ID: 30504718
[TBL] [Abstract][Full Text] [Related]
18. C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades.
Shi YC; Zhao H; Yin C; Zeng X; Zhang Q; Xu WP; Wei J; Chen F; Xie WF
Dig Liver Dis; 2013 Oct; 45(10):844-51. PubMed ID: 23816696
[TBL] [Abstract][Full Text] [Related]
19. Identification and expression analysis of a novel CW-type zinc finger protein MORC2 in cancer cells.
Wang GL; Wang CY; Cai XZ; Chen W; Wang XH; Li F
Anat Rec (Hoboken); 2010 Jun; 293(6):1002-9. PubMed ID: 20225202
[TBL] [Abstract][Full Text] [Related]
20. The chromatin modifier MORC2 affects glucose metabolism by regulating the expression of lactate dehydrogenase A through a feed forward loop with c-Myc.
Guddeti RK; Thomas L; Kannan A; Karyala P; Pakala SB
FEBS Lett; 2021 May; 595(9):1289-1302. PubMed ID: 33626175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
